14372: Open-label, Active-controlled, Randomized Study to Evaluate the Efficacy and Safety of an Age-and Body Weight-adjusted Rivaroxaban Regimen Compared to Standard of Care in Children with Acute Venous Thromboembolism

Project: Research project

Project Details

StatusFinished
Effective start/end date8/1/1411/6/17

Funding

  • Bayer HealthCare Pharmaceuticals, Inc.
  • Bayer HealthCare Pharmaceuticals, Inc.